Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

1 passage

abstractpubmed· Abstract 2020· item PMID:32631841

JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk. Topics: Coronavirus Infections, Janus Kinase Inhibitors, Pandemics, Pneumonia, Viral, Pulmonary Embolism